Crossmark

Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)

Published Online: 2019-01-16

Published Print: 2019-12

Authors

Khanna, Dinesh https://orcid.org/0000-0003-1412-4453
Clements, Philip J.

Volkmann, Elizabeth R.

Wilhalme, Holly

Tseng, Chi-hong

Furst, Daniel E.

Roth, Michael D.

Distler, Oliver

Tashkin, Donald P.
Funding

Funding for this research was provided by:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (k24 AR063120)
License Information

Text and Data Mining valid from 2019-01-16

Version of Record valid from 2019-01-16
More Information

Article History

Received: 14 November 2018

Accepted: 2 January 2019

First Online: 16 January 2019

Ethics approval and consent to participate

: The study protocols for both SLS-I and II were approved by the local Institutional Review Boards, and written informed consent was obtained from all participants.

: Not applicable.

: Boehringer Ingelheim was not involved in directing the content of the manuscript and was only given the opportunity to review the manuscript for factual accuracy.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current